Here’s why I’m confused: if the primary endpoi

Here’s why I’m confused: if the primary endpoint was met, why not PR that? Instead we as investors have to wait until regulatory discussions are complete to get a PR? No biotech or BP ever has reached their primary endpoint but delayed releasing that because of discussions with the FDA.

My thought: 28 day mortality failed BUT mortality at 42 days or X days was stat sig reduced. CYDY is going to shop that data around for approval. No reason to shop around primary endpoint that is met.